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An emerging topic in plant biology is whether plants display
analogous elements of mammalian programmed cell death during
development and defense against pathogen attack. In many plant–
pathogen interactions, plant cell death occurs in both susceptible
and resistant host responses. For example, specific recognition
responses in plants trigger formation of the hypersensitive re-
sponse and activation of host defense mechanisms, resulting in
restriction of pathogen growth and disease development. Several
studies indicate that cell death during hypersensitive response
involves activation of a plant-encoded pathway for cell death.
Many susceptible interactions also result in host cell death, al-
though it is not clear how or if the host participates in this
response. We have generated transgenic tobacco plants to express
animal genes that negatively regulate apoptosis. Plants expressing
human Bcl-2 and Bcl-xl, nematode CED-9, or baculovirus Op-IAP
transgenes conferred heritable resistance to several necrotrophic
fungal pathogens, suggesting that disease development required
host–cell death pathways. In addition, the transgenic tobacco
plants displayed resistance to a necrogenic virus. Transgenic to-
bacco harboring Bcl-xl with a loss-of-function mutation did not
protect against pathogen challenge. We also show that discrete
DNA fragmentation (laddering) occurred in susceptible tobacco
during fungal infection, but does not occur in transgenic-resistant
plants. Our data indicate that in compatible plant–pathogen inter-
actions apoptosis-like programmed cell death occurs. Further,
these animal antiapoptotic genes function in plants and should be
useful to delineate resistance pathways. These genes also have the
potential to generate effective disease resistance in economically
important crops.
programmed cell death u resistance
Regulation of cell death often is crucial to the outcome ofplant–pathogen interactions. Host cell death can occur in
both resistant (incompatible) and susceptible (compatible)
plant–pathogen interactions, although the mechanism(s) and
relevant pathways are poorly understood. In either case, patho-
gen challenge can trigger groups of plant cells to die. The cellular
characteristics of the death process strongly implicates specific
signals and autonomous cellular biochemical processes that
execute individual cells. Recent findings show similarities in
microbial infection mechanisms of animals, humans, and plants
(1–3). An emerging question concerns whether common features
exist between programmed cell death pathways in plants and
those in other eukaryotes. In animals, programmed cell death
(PCD), or its morphological equivalent, apoptosis, is genetically
controlled cellular suicide (4). It is a complex process essential
for development, maintenance of cellular homeostasis, and
defense against environmental insults including pathogen attack.
Apoptosis induces characteristic morphological and biochemical
alterations in cells and results in the orchestrated disassembly of
the cell in a noninflammatory manner (5, 6).
Many incompatible plant–pathogen interactions induce hy-
persensitive lesions and activate host defense mechanisms (7).
The hypersensitive response has been defined as rapid, localized
death of plant cells associated with resistance to pathogen attack.
This response is invoked by pathogenic fungi, viruses, bacteria,
and nematodes (8). Visually, this reaction appears as a region of
dead cells at the point of pathogen recognition by the plant.
Although this scenario resembles PCD in mammalian systems,
specific illustrations of a functionally conserved program in
plants exhibiting the hallmark characteristics of PCD are limited
and molecular details of this process in plants remain unclear (9).
One of the few examples of apoptosis in plant disease resistance
is described by Ryerson and Heath (10), where hypersensitive
resistance in cowpea to the cowpea rust fungus (Uromyces
vignae) is accompanied by degradation of host DNA into oligo-
nucleosomal fragments as well as terminal deoxynucleotidyl-
transferase-mediated UTP end labeling-positive cells, both com-
mon events in PCD. Similar indicators of PCD can appear in the
diseased state (susceptible or compatible reaction). For example,
in plants that are sensitive to toxin-producing fungi, e.g., Fusar-
ium moniliforme, Alternaria alternata, and Cochliobolus victoriae,
certain features of apoptosis are observed (11, 12). In addition,
cucumber mosaic virus D satellite RNA has been shown to
induce morphological features of PCD in infected tomato (13).
Thus, PCD in plants can accompany both susceptible and
resistant reactions, suggesting that overlapping biochemical
pathways are operative in these two contrasting outcomes.
Apoptosis in animals is controlled through functionally con-
served genes, initially identified in Caenorhabditis elegans (14,
15). Both proapoptotic (CED-3, CED-4) and antiapoptotic
(CED-9) regulators have been identified in C. elegans, as have
the analogous mammalian counterparts, namely, caspases,
APAF-1, and Bcl-2, respectively (reviewed in ref. 4). A key
finding is the complementation of nematode CED-9 by human
Bcl-2 (16), indicating functional conservation between nema-
tode and human cell death pathways. Genes of the Bcl-2 family
have been identified in mammalian viruses, Drosophila, and
mice,amongothers.Moreover, twoclassesofbaculovirusantiapo-
ptotic proteins [p35 and inhibitor of apoptosis (IAP)] inhibit
apoptosis in humans, and certain human IAPs are functional in
flies with IAP defects (17). Thus, regulators of cell death are
functionally conserved across broad taxonomic distances within
animals.
In light of these observations, we undertook a transgenic,
‘‘comparative pathobiology’’ approach to evaluate effects of
known regulators of animal apoptosis on plant–pathogen inter-
actions. We focused these studies on several negative regulators
of apoptosis. Specifically, we generated transgenic tobacco
plants expressing: (i) human bcl-2, (ii) human bcl-xl, (iii) nem-
atode ced-9, and (iv) baculovirus op-iap. All of the products of
these genes suppress cell death in appropriate cellular contexts
Abbreviations: PCD, programmed cell death; IAP, inhibitor of apoptosis; TSWV, tomato
spotted wilt virus.
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(18–21). Given the broad taxonomic occurrence of regulators of
PCD, coupled with structural and functional overlap among
these proteins, we examined the phenotypical consequences of
expressing this selected subset of genes in plants exposed to
pathogen challenge. We demonstrate that expression of bcl-2,
bcl-xl, ced-9, or op-iap in tobacco confers heritable resistance to
three important fungal phytopathogens. In addition, these same
transgenic plants show resistance to tomato spotted wilt virus
(TSWV). We further show that DNA laddering occurs in
susceptible but not resistant transgenic tobacco tissue during the
normal course of infection by Sclerotinia sclerotiorum, a broad
host range, necrotrophic fungus.
Materials and Methods
Plasmid Constructions and Plant Transformation. The following
antiapoptotic cDNA genes were used: (i) human bcl-2 [obtained
from S. Korsmeyer, Dana–Farber Cancer Institute, Boston (19)],
(ii) bcl-xl [obtained from C. Thompson, University of Chicago
(20)], (iii) C. elegans ced-9 [obtained from R. Horvitz, Massa-
chusetts Institute of Technology, Cambridge (15)], and (iv)
Baculovirus op-iap [obtained from L. Miller, University of
Georgia, Athens (21)]. Separate binary vectors were constructed
that contained these genes under the control of the caulif lower
mosaic virus 35S promoter and the Agrobacterium nopaline
synthase terminator (22).
For bcl-2 and ced-9 constructs, based on available sequence
information, PCR primers were designed that introduced an
NcoI site at the 59 end of the ORF and an XbaI site at the 39 end
of the ORF. For bcl-2, the following primers were used: 59-
TTTTTCCTCTGGGAGGGCCATGGCGCACGCTGG-39
and 59-TTTTTTCTAGATGCTCTTCGGGCGTGG-39.
For ced-9, the following primers were used: 59-GAATTCCG-
GTTTGAGCCATGGCGACACGCTGCACGGCG-39 and 59-
TTTTTTCTAGAAATACGTTACTTCAAGCTG-39. PCR
was performed and the products were digested with NcoI and
XbaI and subcloned into the plant expression cassette pRTL2
(23). The expression cassettes containing bcl-2 and ced-9 were
subcloned into the binary vector pPZP212 (24) as HindIII
fragments. The resulting constructs are referred to as pPTN161
and pPTN147, respectively. A similar strategy was used for
Op-IAP, except that NcoI and BamHI sites were engineered by
PCR by using the following primer set: 59-GTTGCAGACCAT-
GGCCAGCTCCCGAGCAATTGGC-39 and 59-TTTTTG-
GATCCTTTTATTGTTACACTTGG-39. The op-iap construct
is referred to as pPTN148.
Bcl-xl wt was digested with XbaI and BspHI and subcloned into
pRTL2. The resulting plasmid was digested with PstI and ligated
into pPZP211. To generate a point mutation in bcl-xl, the gene
was amplified with primers harboring a G-to-A substitution at
codon 138 (G138A). This site-directed mutation was inserted
into pZP211 in an identical manner.
Agrobacterium tumefaciens strain C58C1 (25) was used in all
tobacco transformations. The binary vectors pPTN147 (ced-9),
pPTN148 (op-iap), pPTN161 (bcl-2), pPTN250 (bcl-xl), and
pPTN251 (bcl-xl-G138A) were mobilized into C58C1 by tripa-
rental mating (26). Agrobacterium transconjugants were selected
on AB minimal medium supplemented with streptomycin (100
mgyliter), spectinomycin (100 mgyliter), rifampicin (50 mgyli-
ter), gentamycin (50 mgyliter), and sucrose at 1.5% (wtyvol).
Tobacco leaf tissue (cv. Glurk, genotype NN; Turkish, genotype
nn) was transformed and plants were regenerated as de-
scribed (27).
DNAyRNA Isolation and Electrophoresis. DNA and RNA from
tobacco leaves were isolated as described (28, 29). RNA blot
hybridization and membrane washing were performed under
stringent conditions (30). Immunoblots were done as described
(31). Anti-human Bcl-2 antiserum was provided by J. Reed (The
Burnham Institute, La Jolla, CA) (32), and antibody to Bcl-xl was
from Chemicon. IAP antiserum was not available. The CED-9
antibody was kindly provided by H. R. Horvitz and Brad Hersh
(Massachusetts Institute of Technology, Cambridge). ELISA
detection of TSWV was done with a Pathoscreen kit (Agdia,
Elkhart, IN).
Plant Inoculation and Disease-Resistance Assays. The following
fungi were evaluated: Sclerotinia sclerotiorum isolate 1980 (33),
Botrytis cinerea (ATCC 11542), and Cercospora nicotianae (kind-
ly provided by G. Upchurch, North Carolina State University,
Raleigh). In addition, transgenic tobacco plants were tested for
reaction to a necrogenic virus, TSWV. Transgenic and control
tobacco were grown at 25°C with 16-h light periods in the
greenhouse. Leaves of 5-week-old tobacco plants were used for
all experiments. Detached-leaf assays were experimentally con-
venient, and they responded similarly to inoculated whole plants
under greenhouse conditions.
For fungal detached-leaf assays, a minimum of two leaves per
plant from a minimum of five independently transformed plant
lines per transgene of both tobacco cultivars were inoculated by
placing 5-mm-diameter agar plugs containing actively growing
hyphal tips from 3-day-old colonies of either S. sclerotiorum or
B. cinerea grown on potato dextrose agar. For inoculation with
C. nicotianae, spore suspensions were sprayed directly on leaves.
Spores were obtained by following standard procedures (34) and
sprayed as a conidial suspension (104 conidia per ml) on tobacco
plants until run-off. For viral assays, detached tobacco leaves
were dusted with carborundum and rub-inoculated with TSWV-
infected plant sap diluted 1:25 (wtyvol) in 10 mM sodium
phosphate buffer, pH 7y10 mM sodium sulfite. After 5 min,
leaves were washed thoroughly with water, placed in Petri dishes,
and held at 25°C under constant illumination.
Leaves were placed on moistened sterile filter paper in glass
Petri dishes and incubated for 3–7 days at 25°C and high
humidity. All treatments were repeated on whole plants with
similar results. Inoculated plants were placed in a mist chamber
at 100% relative humidity at 25°C. A minimum of five indepen-
dently transformed plant lines per transgene were used. All
experiments were repeated at least three times.
Results
Establishment of Transgenic Plants and Analysis of Gene Expression.
Single or low-copy-number, kanamycin-resistant transgenic to-
bacco plants harboring the various antiapoptotic genes were
selected after Southern blot analysis (not shown). Nontrans-
formed tobacco and tobacco containing vector alone served as
controls. Glurk and Turkish lines were obtained with each of the
transgenes (ced-9, bcl-2, bcl-xl, and op-iap). Northern blot anal-
ysis confirmed the expression of the transgenes, and protein
expression levels in these plants were quantified by Western blot
analysis (Fig. 1 and data not shown).
Bcl-2 Family of Proteins and Op-IAP Confer Resistance to Fungal
Pathogens. When transgenic tobacco harboring Bcl-2, CED-9, or
Op-IAP was inoculated with S. sclerotiorum, plants were highly
tolerant to this pathogen and, in most cases, completely resistant
to infection. In contrast, plants transformed with vector alone or
nontransformed tobacco were highly and typically susceptible
(Fig. 2A). S. sclerotiorum requires inoculation with a nutritional
source, unlike most other fungi that can incite disease when
delivered in water or buffer alone. As shown in Fig. 2 A, the
fungus, when inoculated with a rich nutritional source, grew
vegetatively along the leaf surfaces of plants expressing the
antiapoptotic genes, without infecting host tissue. The fungus
eventually ceased growth, presumably because the nutritional
source became depleted; even with extended incubation, the
fungus still failed to colonize and infect plant tissue. In contrast,
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the fungus on control plants completely colonized and macer-
ated leaf tissue during the same time period (Fig. 2 A). B. cinerea,
also a broad-host-range necrotrophic fungal pathogen, showed a
similar response when inoculated to the same transgenic tobacco
lines (Fig. 2C and data not shown). C. nicotianae produces a
non-host-specific toxin, cercosporin, which is required for patho-
genicity. Tobacco harboring Bcl-2 was strikingly resistant to this
pathogen (Fig. 2E), whereas wild-type tobacco was extremely
sensitive; intact plants were dead within 2 weeks. Transgenic
tobacco with CED-9 and Op-IAP expressed symptoms, albeit to
a reduced extent relative to control plants (Fig. 2E). Although
C. nicotianae-infected tobacco containing CED-9 and Op-IAP
showed symptoms of toxin-induced disease, these plants as well
as the Bcl-2 tobacco all survived the inoculation and set seed, in
contrast to the wild-type plants that were killed before they could
set seed.
The tobacco plants were selfed for genetic analysis. A total of
15 kanamycin-sensitive progeny plants lacking transgene expres-
sion were susceptible to all tested fungi, whereas plants selected
for kanamycin resistance and transgene expression were resis-
tant and generally identical in phenotype to the parental,
primary transformant (e.g., Fig. 2 B and D, S. sclerotiorum and
B. cinerea inoculations, respectively). Progeny leaves in Fig. 2B
were similar in size when inoculated. The susceptible leaf (Fig.
2B Lower Right) became extensively macerated. In all cases, the
fungal resistance phenotypes mediated by bcl-2, ced-9, or op-iap
transgenes appeared to be dominant and cosegregated with the
selectable marker gene. Both Turkish and Glurk cultivars re-
sponded identically after fungal challenge, indicating no tobacco
genotype-specific effects in the transgenic plants after pathogen
challenge.
Bcl-2 Family Proteins and Op-IAP Confer Resistance to a Viral Patho-
gen. Plants expressing antiapoptotic genes also were challenged
with TSWV. Certain plant host–virus combinations produce
Fig. 1. Western blot assays of expression of Bcl-2-related proteins in vitro
and in transformed tobacco lines. (A) CED-9 expression. Lanes: 1, His-tagged
CED-9; 2, wild-type tobacco; 3–10, separate ced-9 transgenic plants. (B) Bcl-2
expression. Lanes: 1, monkey kidney cells expressing His-tagged Bcl-2; 2,
wild-type tobacco; 3–10, separate bcl-2-transgenic plants. (C) Bcl-xl expression.
Lanes: 1, monkey kidney cells expressing His-tagged Bcl-xl; 2, wild-type to-
bacco; 3–6, separate bcl-xl-transgenic plants; 7–10, transgenic (susceptible)
plants with bcl-xl-G138A.
Fig. 2. Antiapoptotic genes confer resistance to necrotrophic fungi in transgenic plants. Detached Glurk tobacco leaves were inoculated with three species of
fungi. (A) Leaves inoculated with S. sclerotiorum from plants transformed with bcl-2, ced-9, bcl-xl, or op-iap, as indicated. Leaf V is from a plant transformed with
binary vector pZP212 alone. (B) Leaves inoculated with S. sclerotiorum from F1 progeny of plants transformed with ced-9. (C) Leaves inoculated with B. cinerea
from plants transformed with bcl-2 or ced-9, as indicated. (D) Leaves inoculated with B. cinerea from F1 progeny of plants transformed with bcl-2. (E) Leaves
inoculated with C. nicotianae from plants transformed with bcl-2, ced-9, or op-iap, as indicated. In A, C, and E, WT indicates a leaf from an untransformed control
plant. In B and D, the leaf shown at Lower Right is from a kanamycin-sensitive F1 plant.
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necrotic lesions as a disease symptom, regardless of host geno-
type. In such combinations the plant is called a local lesion host
of the virus. TSWV causes large, spreading necrotic lesions on
inoculated leaves (35), followed by systemic infection and ne-
crosis. Typical lesions were observed on control plants for TSWV
(Fig. 3). Necrotic symptoms were greatly reduced or absent on
the tobacco leaves expressing Bcl-2 (not shown) as well as CED-9
and Op-IAP after inoculation with TSWV (Fig. 3). Like the
fungal pathogens, this effect was independent of the tobacco
genetic background because transgenic Turkish and Glurk cul-
tivars gave identical results. However, we have preliminary
evidence that a cultivar-specific HR is not inhibited by these
genes because tobacco mosaic virus induced local lesions on all
four types of transgenic Glurk tobacco, which has the N gene for
resistance (unpublished data).
ELISA assays demonstrated that both necrotic lesions and
surrounding areas of inoculated leaves of the control plants
contained TSWV proteins (Fig. 4). On the Bcl-2, CED-9, and
Op-IAP plants, however, TSWV proteins were present in the
inoculated areas of the leaves but were not detectable in the
surrounding, uninoculated regions of the leaves immediately
adjacent to the inoculated region (Fig. 4). This suggests that virus
spread from the site of inoculation was impaired in Bcl-2,
CED-9, and Op-IAP plants. The resistance phenotypes also
cosegregated with the transgenes in the progeny of selfed plants.
Pathogen Resistance Is Reversed by Loss-of-Function Mutation. An
important consideration in these observations is the question:
Are these antiapoptotic gene products directly affecting cell
deathyresistance pathways in the plant or are they causing a
general, stress response in the plant that accounts for resistance?
To address this question, we generated an additional set of
transgenic tobacco expressing the Bcl-2 family member Bcl-xl
and Bcl-xl containing a G138A mutation (Fig. 1B, lanes 6–9).
Glycine 138 is located in the conserved BH-1 domain of Bcl-xl,
which is essential for its antiapoptotic activity (36). Results from
10 independent, transformed tobacco lines indicate that Bcl-xl
protects tobacco from S. sclerotiorum infection, as was the case
for Bcl-2 (Fig. 5). Significantly, the mutant Bcl-xl (G138A)
expressing tobacco responded as untransformed control plants
although in some lines lesions were slower to develop (Fig. 5).
Selfed Bcl-xl plants also showed segregation of resistance and
transgene expression (data not shown). None of the selfed
progeny containing the G138A mutation showed resistance.
Western blot analysis of these tobacco lines showed equivalent
steady-state protein levels in both Bcl-xl (wt) and Bcl-xl (G138A)
lines (Fig. 1B). Thus, our data indicate that resistance to S.
sclerotiorum requires a functional Bcl-xl protein.
Disease Development and Apoptosis. One classical biochemical
method for demonstrating apoptosis is the presence of oligonu-
cleosome-sized fragments of DNA that, when electrophoresed
on agarose gels, produce a characteristic ‘‘ladder.’’ Genomic
DNA was isolated from tobacco leaves after inoculation with S.
sclerotiorum. As shown in Fig. 6, lanes 1 and 3, the isolated DNA
was fragmented and formed characteristic ladders. Lane 1 shows
DNA isolated 4 h after inoculation and lane 3 shows it 8 h after
inoculation. There were no macroscopic symptoms at either time
point, but, by 8 h, fungal growth was evident. By 18 h postin-
oculation, symptoms of disease were clearly visible (Fig. 2 A).
Fig. 3. Transgenic plants expressing antiapoptotic genes have altered re-
sponse to TSWV. TSWV lesions on detached Glurk tobacco leaves. (A) Three
leaves from plants expressing CED-9. (B) Three leaves from Op-IAP-expressing
plants. In both A and B, leaf 4 is from an untransformed control plant.
Fig. 4. ELISA of TSWV accumulation in detached leaves from transformed
tobacco lines. Wells 1 and 2, positive and negative controls, respectively. Wells
3, 5, and 7 are samples from inoculated half-leaves; wells 4, 6, and 8 are from
the uninoculated half of the same leaves. Plants are transformed with vector
only (wells 3 and 4), with ced-9 (wells 5 and 6), or with op-iap (wells 7 and 8).
Fig. 5. Plants expressing wild-type Bcl-xl, but not mutant Bcl-xl, are resistant
to S. sclerotiorum. Shown are detached Glurk tobacco leaves inoculated with
S. sclerotiorum. Leaves A and B are from plants transformed with bcl-xl, and
leaves C and D are from plants transformed with mutant bcl-xl (G138A).
Fig. 6. DNA laddering in susceptible tobacco after inoculation with S.
sclerotiorum. Ethidium bromide-stained agarose gel of DNA extracted from
nontransgenic tobacco (lanes 1 and 3) and the transgenic line expressing Bcl-2
(lanes 2 and 4) after challenge with S. sclerotiorum. DNA was extracted 4 (lanes
1 and 2) and 8 h (lanes 3 and 4) postinoculation.
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Thus, before discernible disease development occurred, the
fungus was inducing DNA fragmentation in the host plant. Of
note, transgenic tobacco harboring Bcl-xl not only was resistant
to the fungus, but DNA laddering did not occur during the same
time period (Fig. 6, lanes 2 and 4) or even later time points (not
shown). Similar results occurred with tobacco harboring CED-9
and Bcl-2 (not shown). These observations suggest that S.
sclerotiorum induces PCD during successful infection. Further,
this pathogen-induced plant cell death has some similarity to
PCD in animals.
Effects of Transgene Expression on Plant Physiology. Transgenic
tobacco constitutively expressing IAP grew, flowered, and set
seed in a manner similar to wild-type tobacco, with no detectable
morphological or physiological alterations. However, plant
growth and morphology were affected in some lines expressing
either Bcl-2, Bcl-xl, or CED-9. Lines with high Bcl-2 expression
were male sterile. High-Bcl-xl-expressing lines also were male
sterile and stunted, and they exhibited stem bleaching, f lower
deformation, and slightly altered leaf pigmentation (data not
shown). CED-9 transgenic plants had variegated leaf pigmen-
tation. These highly expressing transgenic plant lines were also
extremely resistant to the pathogens tested. In contrast, moder-
ately expressing transgenic lines (e.g., Figs. 2 and 3) showed
none of these altered growth patterns but retained pathogen
resistance.
Discussion
The indispensable role of PCD in higher eukaryotic develop-
ment and its response to environmental stress and pathogen
attack is well established. Here, we show that negative regulators
of apoptosis, when expressed in tobacco, conferred resistance
phenotypes to several fungal pathogens and TSWV under con-
ditions that normally result in necrotic disease. Moreover, we
show that DNA ladders were induced specifically during disease
development by a fungal pathogen but not in plants expressing
cytoprotective antiapoptotic genes. Although any single criterion
is not conclusive, these results are consistent with the model that
S. sclerotiorum induces disease in tobacco by activating a plant
PCD pathway. This pathway was inhibited by animal antiapo-
ptotic genes, thereby preventing fungal colonization, DNA frag-
mentation, and subsequent disease development.
Coupled with recent reports, these data considerably
strengthen the parallels between the hypersensitive response in
plants and PCD in animals. For example, Bcl-xl and CED-9 have
been reported to protect tobacco plants from cell death induced
by either UV irradiation or paraquat treatment (37). In addition,
in temperature-shift experiments after tobacco mosaic virus
inoculation with Bcl-xl transgenic plants, expression of patho-
genesis-related proteins PR1 and PR3 was reduced and expres-
sion of tobacco mosaic virus coat protein was increased. Lesion
size was reported to be slightly larger in the transgenic plants
(37), although the overall role of these transgenes with respect
to plant disease remained an open question. Previous studies
showed that tomato protoplasts treated with the mycotoxin
fumonisin B1 underwent PCD-like response as indicated by
DNA ladders and terminal deoxynucleotidyltransferase-
mediated UTP end labeling-positive reacting cells (11). Re-
cently, Ausubel and colleagues (38, 39) have shown that fumo-
nisin B1 treatment of Arabidopsis protoplasts results in terminal
deoxynucleotidyltransferase-mediated UTP end labeling-
positive reacting cells and also that toxin infiltration of intact
plants resulted in cell death, generation of reactive oxygen
intermediates, and other biochemical markers associated with
plant defense responses. Those authors also suggested that
toxin-mediated PCD may be important during successful plant
infection by pathogens. Bax, a death-promoting member of the
Bcl-2 family known to kill yeast cells (40, 41), recently was
introduced and expressed in tobacco cells. Cell death of these
tobacco cells occurred in a manner similar to hypersensitive
response (42). However, no distinctive morphological changes
occurred, although Bax did localize to mitochondria. To date, no
plant homologues of caspases or Bcl-2-like proteins have been
identified, although caspase-like activity has been detected (43).
Further, cysteine proteases are important in a number of plant
PCD situations, including senescence (44, 45), xylogenesis (46),
and oxidative stress (47). It is possible that functional analogs
may be obscure at the sequence level, which is consistent with the
divergence of plant and animal species. However, there is
growing circumstantial evidence that similar pathways exist in
plants and animals. Thus, although the extent to which animal
and plant apoptosis pathways overlap is not yet resolved, there
are several examples plant cell death accompanied by features of
apoptosis.
A unifying aspect of our results with the fungi tested is the fact
that all three pathogens are necrotrophs, i.e., they require host
plant cell death to grow, colonize, and reproduce in the plant. In
the case of S. sclerotiorum, it has been assumed that this
aggressive, indiscriminate pathogen, with an impressive arsenal
of degradative enzymes and toxins, simply ramifies through
defenseless plant tissue. Our data suggest that this interaction is
more sophisticated—that the pathogen specifically interacts with
the plant by triggering host-cell-death pathways. Inhibition of
this pathway presumably by antiapoptotic gene products pre-
vents fungal infection despite the fact that the fungus has its full
complement of virulence determinants. Necrotrophic pathogens
may need to co-opt plant host apoptotic pathways for successful
colonization and subsequent disease development. Suppression
of plant cell death may improve resistance to necrotrophs.
The effect of Bcl-2 expression on C. nicotianae infection is of
interest. This fungus synthesizes a light-activated polyketide
toxin, cercosporin (48). CED-9- and IAP-containing transgenic
tobacco plants were symptomatic but highly tolerant. Bcl-2
transgenic plants, on the other hand, were extremely resistant
(Fig. 2E). Cercosporin generates reactive oxygen species such as
singlet oxygen, which is required for induction of host cell death.
Bcl-2 reportedly interferes with cell death mediated by reactive
oxygen possibly by promoting the scavenging of free radicals
(49). Consistent with Bcl-2 protecting plants from reactive
oxygen species is the recent report of paraquat resistance in
transgenic Bcl-xl- and CED-9-containing tobacco (37). Paraquat
is a contact herbicide that kills plant cells by causing the
production of active oxygen species. Moreover, Bcl-2 expression
reduced paraquat-induced apoptosis in mouse cells (50). It will
be of interest to determine whether Bcl-2 functions similarly in
plants, particularly because pathogen attack is known to gener-
ate reactive oxygen species (51).
The mechanisms leading to necrosis in response to virus
infection are poorly understood. Clearly, in the case of TSWV,
lesion formation at the site of inoculation does not prevent
systemic invasion of the plant. However, the transgenes not only
prevented the typical local necrotic response to virus inocula-
tions, but limited virus movement or reproduction as well.
Perhaps, TSWV causes physiological changes in the host before
productive infection, and necrosis is one consequence of this
elicitation. Molecular details of virus-induced symptomatology
are unknown, precluding speculation on the effects of Bcl-2,
CED-9, or Op-IAP. Because these genes also block fungal-
induced necrosis, presumably a common pathway is involved in
both cases.
An important consideration in these experiments concerns the
specificity and mode of action of these transgenes. We believe
these transgenes specifically confer resistance in our experiments
for the following reasons: (i) only transgenic plants were resis-
tant, (ii) inheritance of resistance was strictly correlated with
expression of the transgene, and (iii) a loss-of-function mutant
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of Bcl-xl (G138A) failed to confer resistance under the same
conditions, whereas wild-type Bcl-xl did, and this phenotype also
was evident after selfing of the parent transgenic plants.
The mechanism of action of these antiapoptotic genes in
plants, at present, is conjectural. In preliminary experiments,
there was no consistent pattern of induction of defense genes
(e.g., PR proteins; see Fig. 7, which is published as supplemental
data on the PNAS web site, www.pnas.org) across independently
generated transgenic lines, but we cannot rule out that these
genes may, in some cases, trigger known defense-signaling
pathways (e.g., salicylic acid, jasmonic acid). Even in mammalian
systems, it is not entirely clear how, for example, Bcl-2 promotes
cell survival. Several mechanisms have been proposed to explain
how Bcl-2 prevents apoptosis (52), including prevention of
cytochrome c release from mitochondria, prevention of reactive
oxygen-induced cell death, dimerization with and inactivation of
death-promoting apoptotic proteins such as Bax, and sequestra-
tion of caspase-activating proteins.
The IAP family of proteins likewise is important for the
suppression of programmed cell death. Several IAPs are caspase
inhibitors (16), but some IAPs clearly do not have any antiapo-
ptotic function. In yeast and nematodes, IAP proteins are
involved in cell division and cytokinesis, respectively (53, 54).
Moreover, the molecular mechanism of the baculoviral IAP
suppression of cell death is not entirely clear because no protease
target is known. Given that no molecular markers involving plant
cell-programmed cell death have been identified, it is premature
to speculate on the mechanisms underlying our results. That
characteristic DNA fragmentation was observed during success-
ful fungal attack provides compelling evidence that there is at
least some overlap between plant and animal cell death pro-
cesses. It will be of interest to determine more precisely how
these gene products interact with plant cells. These transgenes
may serve as tools to dissect cell death pathways in plants.
Moreover, these transgenes are viable candidates for engineer-
ing resistance into economically important crop plants.
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Editorial Expression of Concern and Corrections
CELL BIOLOGY. EDITORIAL EXPRESSION OF CONCERN: The editors ex-
press a note of concern regarding the article ‘‘Preferential repair
of ionizing radiation-induced damage in the transcribed strand
of an active human gene is defective in Cockayne syndrome,’’
by Steven A. Leadon and Priscilla K. Cooper, which appeared
in issue 22, November 15, 1993, of Proc. Natl. Acad. Sci. USA
(90, 10499–10503).
An ad hoc committee at the University of North Carolina at
Chapel Hill (UNC) has concluded that the results published by
Dr. Steven A. Leadon, former Professor of Radiation Oncology
in the School of Medicine at UNC, which are based on his
monoclonal antibody assays for transcription-coupled repair
(TCR), should not be relied on unless independent verification
exists.
After reviewing laboratory notebooks, the investigating com-
mittee could not confirm that equal amounts of DNA were
loaded onto gel lanes that were then assayed for TCR. The
committee concluded that the reported preferential repair of the
transcribed DNA strand was not supported by available photo-
graphs of ethidium bromide-stained gels. The committee further
concluded that Dr. Leadon was solely responsible, at least for the
last 7 years, for the step of the assay that determined the loading
of the gel lanes. In addition, in the opinion of the UNC committee,
this biased loading was deliberate and done without the knowl-
edge of other scientists in his laboratory or his collaborators.
As a consequence of this investigation, the UNC committee
requested that PNAS evaluate the results of the above-cited
paper, which depends critically, but not exclusively, on Dr.
Leadon’s TCR assay.
We have investigated the matter and are concerned about the
validity of the results. We know of no independent verification
of the data in the published figures. We therefore think it
reasonable for the scientific community to view with extreme
caution the results of these assays in the PNAS article. The
editors emphasize that our skepticism does not extend to the
validity of TCR, which has been amply corroborated by other
experiments.
The coauthor S.A.L. does not concur with this assessment and
note of concern. Although coauthor P.K.C. cannot of her own
knowledge dispute the stated concern with the TCR data, she
attests that the conclusions from the paper are valid, based on
subsequent work in several laboratories, including her own.
Nicholas R. Cozzarelli, Editor-in-Chief
www.pnas.orgcgidoi10.1073pnas.2034938100
NEUROSCIENCE. For the article ‘‘Trace amounts of copper in water
induce -amyloid plaques and learning deficits in a rabbit model
of Alzheimer’s disease,’’ by D. Larry Sparks and Bernard G.
Schreurs, which appeared in issue 19, September 16, 2003, of
Proc. Natl. Acad. Sci. USA (100, 11065–11069; first published
August 14, 2003; 10.1073pnas.1832769100), the authors note
typographical errors in refs. 8, 10, 11, 25, 28, and 29. The
corrected references appear below.
8. Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M. E.,
Romano, D. M., Hartshorn, M. A., Tanzi, R. E. & Bush, A. I. (1998) J. Biol.
Chem. 21, 12817–12826.
10. White, A. R., Multhaup, G., Galatis, D., McKinstry, M. W., Parker, M. W.,
Pipkorn, R., Beyreuther, K., Masters, C. L. & Cappai, R. (2002) J. Neurosci.
22, 365–376.
11. Maynard, C. J., Cappai, R., Volitakis, I., Cherny, R. A., White, A. R.,
Beyreuther, K., Masters, C. L., Bush, A. I. & Li, Q.-X. (2002) J. Biol. Chem.
277, 44670–44676.
25. Sparks, D. L., Kuo, Y.-M., Roher, A., Martin, T. & Lukas, R. J. (2000) Ann.
N.Y. Acad. Sci. 903, 335–344.
28. Sparks, D. L., Lochhead, J., Horstman, D., Wagoner, T. & Martin, T. (2002)
J. Alzheimer’s Dis. 4, 523–529.
29. Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L. & Markesbery,
W. R. (1998) J. Neurol. Sci. 158, 47–52.
www.pnas.orgcgidoi10.1073pnas.2135351100
PLANT BIOLOGY. For the article ‘‘Abrogation of disease develop-
ment in plants expressing animal antiapoptotic genes,’’ by M. B.
Dickman, Y. K. Park, T. Oltersdorf, W. Li, T. Clemente, and R.
French, which appeared in issue 12, June 5, 2001, of Proc. Natl.
Acad. Sci. USA (98, 6957–6962; first published May 29, 2001;
10.1073/pnas.091108998), the authors note that the Bcl-2 was
inserted in the 3 UTR and consisted of noncoding RNA.
Therefore, the pictures of the Bcl-2 leaves in Fig. 2, while
technically harboring Bcl-2 DNA, did not contain the open
reading frame and Bcl-2 protein. The results and conclusions
based on Fig. 1B are therefore invalid.
www.pnas.orgcgidoi10.1073pnas.2034612100
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Fig. 7. Expression analysis of defense-associated genes in transgenic plants. Total RNA from 
transgenic plants containing Bcl-2, Bcl-xl, Op-IAP, CED-9, and E1B-19K (adenovirus) was 
isolated from leaf tissue. RNA from empty vector transgenic and wild-type Glurk plants served 
as controls. Probes were obtained from clones derived from tobacco (Syngenta; Basel). An 
Arabidopsis 18S ribosomal DNA fragment served as an internal control for equivalent RNA 
loading. The adenovirus E1B-19K gene was used in our initial plant transformation experiments 
as described in the text for the other anti-apoptotic gene constructs. The E1B-19K-containing 
plants did not exhibit resistance to any of the pathogens we used and thus were no longer studied. 
It is important to note that even though E1B-19K-containing tobacco were not resistant, 
transcript levels for certain PR protein genes (e.g., PR-1 and PR-3) were quite high.  
 
